This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Factory, Inc.. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Tutomu Uehara: Innovator in Sodium Ion Absorption Inhibition
Introduction
Tutomu Uehara is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of medical science, particularly in the development of agents that address health issues related to excessive salt intake. His innovative work has the potential to improve the quality of life for many individuals.
Latest Patents
Uehara holds a patent for "Sodium ion absorption inhibitors, sodium ion excretion accelerators, and preventive and therapeutic agents for diseases resulting from excessive intake of common salt." This patent describes a sodium ion absorption inhibitor, a sodium ion excretion accelerator, and an agent for preventing and treating diseases caused by excessive common salt ingestion. Each of these agents comprises a metal salt (excluding sodium salt) of lambda-carrageenan as an active ingredient. They are designed to excrete excessively ingested common salt from the body positively and safely, particularly excelling in the excretion of sodium ions into feces.
Career Highlights
Tutomu Uehara is currently employed at Otsuka Pharmaceutical Factory, Inc., where he continues to innovate and contribute to the field of pharmaceuticals. His work focuses on developing solutions that can mitigate the health risks associated with high sodium consumption.
Collaborations
Uehara collaborates with talented individuals such as Takaya Sato and Ippei Yamaoka, who share his commitment to advancing medical science and improving public health.
Conclusion
Tutomu Uehara's contributions to the field of sodium ion absorption inhibition represent a significant advancement in medical science. His innovative patent and ongoing work at Otsuka Pharmaceutical Factory, Inc. highlight his dedication to improving health outcomes related to salt intake.